Feedback (FDBK)

Sector:

Health Care

Index:

FTSE AIM All-Share

 82.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 140.00
  • 52 Week Low: 58.00
  • Currency: UK Pounds
  • Shares Issued: 13.33m
  • Volume: 10,130
  • Market Cap: £11.00m
  • RiskGrade: 267
  • Beta: 0.02

Feedback PLC forms cancer diagnosis joint venture

By Michele Maatouk

Date: Monday 05 Oct 2015

LONDON (ShareCast) - (ShareCast News) - Medical imaging software company Feedback PLC announced the incorporation of a joint venture company, Prostate Checker, with Spain's QUIBIM, to develop a product for the detection and diagnosis of prostate cancer.
Feedback said that in order to facilitate this move, it has granted a licence for some of the intellectual property of its TexRAD texture analysis product to Prostate Checker.

Prostate Checker will combine texture analysis with other image analysis parameters from QUIBIM to develop an integrated product which would potentially assist clinicians in diagnosing and assessing treatment options for prostate cancer.

Dr Angel Alberich-Bayarri, chief executive officer of QUIBIM, said: "I am sure that we can develop the most advanced MR imaging solutions for prostate cancer diagnosis in the market which wouldn't be possible with independent strategies."

At 0945 BST, Feedback shares were up 10.1% at 2.45p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Feedback Market Data

Currency UK Pounds
Share Price 82.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 140.00
52 Week Low 58.00
Volume 10,130
Shares Issued 13.33m
Market Cap £11.00m
Beta 0.02
RiskGrade 267

Feedback Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.43% below the market average25.43% below the market average25.43% below the market average25.43% below the market average25.43% below the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average
Price Trend
40.44% below the market average40.44% below the market average40.44% below the market average40.44% below the market average40.44% below the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average
Income Not Available
Growth
51.95% above the market average51.95% above the market average51.95% above the market average51.95% above the market average51.95% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Feedback Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:06 5 @ 85.00p
16:05 9 @ 85.00p
14:57 70 @ 80.25p
12:26 1,261 @ 80.25p
10:40 5,000 @ 84.75p

Feedback Key Personnel

CEO Tom Oakley
CFO Anesh Patel

Top of Page